From CLE to SLE: A Case Report from Local Hospital
Case Report
DOI:
https://doi.org/10.55175/cdk.v52i6.1281Keywords:
Autoimmune disease, cutaneous lupus erythematosus, SLEAbstract
Introduction: Lupus erythematosus (LE) is a combination of various interrelating autoimmune clinical diseases. Cutaneous lupus erythematosus (CLE) is a spectrum of typical autoimmune skin features of systemic lupus erythematosus (SLE). A good recognition of the typical appearance of this skin lesion (CLE) enables diagnosis and good management of SLE. Case: A 26-year-old female with SLE with acute skin lessions (ACLE) skin lesions. Suspicion of SLE became stronger when the antinuclear antibody (ANA) titer reached 1:3,200. The main therapy is methylprednisolone injection followed by a gradual dose reduction. The patient was treated for 6 days in hospital and all lesions improved. Conclusion: The patient in this case had SLE with 6 clinical domains in the EULAR/ACR 2019 criteria and a total score of 34 (>10). Earlier and more accurate diagnosis of SLE can make therapy more effective, especially if CLE is already present.
Downloads
References
Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, et al. Fitzpatrick’s dermatology. 9th Ed. United States: McGraw-Hill Education; 2019. p. 1037.
Tian J, Zhang D, Yao X, Huang Y, Lu Q. Global epidemiology of systemic lupus erythematosus: A comprehensive systematic analysis and modelling study. Ann Rheum Dis. 2023;82(3):351–6. DOI: 10.1136/ard-2022-223035.
Vaillant AAJ, Goyal A, Varacallo M. Systemic lupus erythematosus. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publ. 2023. Available from: http://www.ncbi.nlm.nih.gov/books/NBK535405/.
Aringer M, Petri M. New classification criteria for systemic lupus erythematosus. Curr Opin Rheumatol. 2020;32(6):590–6. DOI: 10.1097/BOR.0000000000000740.
Dima A, Jurcut C, Chasset F, Felten R, Arnaud L. Hydroxychloroquine in systemic lupus erythematosus: Overview of current knowledge. Ther Adv Musculoskelet Dis. 2022;14:1–25. DOI: 10.1177/1759720X211073001.
Borucki R, Werth VP. Expert perspective: An evidence-based approach to refractory cutaneous lupus erythematosus. Arthritis Rheumatol. 2020;72(11):1777–85. DOI: 10.1002/art.41480.
Foulke G, Helm LA, Clebak KT, Helm M. Autoimmune skin conditions: Cutaneous lupus erythematosus. FP Essent. 2023;526:25-36. PMID: 36913660.
Selvaraja M, Too CL, Tan LK, Koay BT, Abdullah M, Shah AM, et al. Human leucocyte antigens profiling in Malay female patients with systemic lupus erythematosus: Are we the same or different? Lupus Sci Med. 2022;9(1):1–14. DOI: 10.1136/lupus-2021-000554.
Tayem MG, Shahin L, Shook J, Kesselman MM. A review of cardiac manifestations in patients with systemic lupus erythematosus and antiphospholipid syndrome with focus on endocarditis. Cureus 2022;14(1):e21698. DOI: 10.7759/cureus.21698.
Jeong DY, Lee SW, Park YH, Choi JH, Kwon YW, Moon G, et al. Genetic variation and systemic lupus erythematosus: A field synopsis and systematic meta-analysis. Autoimmunity Rev. 2018;17:553–66. DOI: 10.1016/j.autrev.2017.12.011.
Tanzilia MF, Tambunan BA, Dewi DNSS. Tinjauan pustaka: Patogenesis dan diagnosis sistemik lupus eritematosus. Syifa’ Med J Kedokt Kes. 2021;11(2):139. DOI: 10.32502/sm.v11i2.2788.
Gounden V, Vashisht R, Jialal I. Hypoalbuminemia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK526080/.
Stull C, Sprow G, Werth VP. Cutaneous involvement in systemic lupus erythematosus: A review for the rheumatologist. J Rheumatol. 2023;50(1):27–35. DOI: 10.3899/jrheum.220089.
Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol. 2019;71(9):1400–12. DOI: 10.1002/art.40930.
Leuchten N, Brinks R, Hoyer A, Schoels M, Aringer M, Johnson S, et al. SAT0415 performance of anti-nuclear antibodies (ana) for classifying systemic lupus erythematosus (SLE): A systematic literature review and meta-regression of diagnostic data. Ann Rheum Dis. 2015;74(Suppl 2):809-10. DOI: 10.1136/annrheumdis-2015-eular.4039.
Kuhn A, Landmann A. The classification and diagnosis of cutaneous lupus erythematosus. J Autoimmun. 2014;48–49:14–9. DOI: 10.1016/j.jaut.2014.01.021.
Herzum A, Gasparini G, Cozzani E, Burlando M, Parodi A. Atypical and rare forms of cutaneous lupus erythematosus: The importance of the diagnosis for the best management of patients. Dermatology 2022;238(2):195–204. DOI: 10.1159/000515766.
Cooper EE, Pisano CE, Shapiro SC. Cutaneous manifestations of “lupus”: Systemic lupus erythematosus and beyond. Int J Rheumatol. 2021;2021:6610509. DOI: 10.1155/2021/6610509.
Fanouriakis A, Kostopoulou M, Alunno A, Aringer M, Bajema I, Boletis JN, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019;78(6):736–45. DOI: 10.1136/annrheumdis-2019-215089.
Azrielant S, Ellenbogen E, Peled A, Zemser-Werner V, Samuelov L, Sprecher E, et al. Diffuse facial hyperpigmentation as a presenting sign of lupus erythematosus: Three cases and review of the literature. Case Rep Dermatol. 2021;13(2):263–70. DOI: 10.1159/000515732.
Joseph AK, Abbas LF, Chong BF. Treatments for disease damage in cutaneous lupus erythematosus: A narrative review. Dermatol Ther. 2021;34(5):e15034. DOI: 10.1111/dth.15034.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Kelvin, Louis Rianto, Linda Julianti Wijayadi
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
